Macrophage CD40 signaling: A pivotal regulator of disease protection and pathogenesis

Seminars in Immunology

Volumn 21, Issue 5, 2009, Pages 257-264

  Suttles, Jill ^a   Stout, Robert D ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

CD154; CD40; Cell signaling; Inflammation; Macrophage; Monocyte

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; B7 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; CD86 ANTIGEN; CYCLOOXYGENASE 2; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; STRESS ACTIVATED PROTEIN KINASE; SUPPRESSOR OF CYTOKINE SIGNALING 3; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 5; UNINDEXED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANTIGEN EXPRESSION; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; CANCER INHIBITION; CARDIOVASCULAR DISEASE; CYTOKINE PRODUCTION; FUNGUS IMMUNITY; GENE EXPRESSION; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; INNATE IMMUNITY; MACROPHAGE; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; MONOCYTE; NONHUMAN; PARASITE IMMUNITY; PATHOGENESIS; PROTECTION; REVIEW; RHEUMATOID ARTHRITIS; SEPSIS; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD40; HUMANS; INFLAMMATION; MACROPHAGES; SIGNAL TRANSDUCTION;

EID: 70349141664     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2009.05.011     Document Type: Review

References (112)

1. van Furth R., and Cohn Z.A. The origin and kinetics of mononuclear phagocytes. J Exp Med 128 (1968) 415-435
2. van Furth R., Diesselhoff-den Dulk M.C., and Mattie H. Quantitative study on the production and kinetics of mononuclear phagocytes during an acute inflammatory reaction. J Exp Med 138 (1973) 1314-1330
3. Kennedy D.W., and Abkowitz J.L. Mature monocytic cells enter tissues and engraft. Proc Natl Acad Sci USA 95 (1998) 14944-14949
4. Kennedy D.W., and Abkowitz J.L. Kinetics of central nervous system microglial and macrophage engraftment: analysis using a transgenic bone marrow transplantation model. Blood 90 (1997) 986-993
5. Laskin D.L., Weinberger B., and Laskin J.D. Functional heterogeneity in liver and lung macrophages. J Leukoc Biol 70 (2001) 163-170
6. Guillemin G.J., and Brew B.J. Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J Leukoc Biol 75 (2004) 388-397
7. Mebius R.E., and Kraal G. Structure and function of the spleen. Nat Rev Immunol 5 (2005) 606-616
8. Stout R.D., and Suttles J. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J Leukoc Biol 76 (2004) 509-513
9. Sypek J.P., Panosian C.B., and Wyler D.J. Cell contact-mediated macrophage activation for antileishmanial defense. II. Identification of effector cell phenotype and genetic restriction. J Immunol 133 (1984) 3351-3357
10. Stout R.D., and Bottomly K. Antigen-specific activation of effector macrophages by IFN-gamma producing (TH1) T cell clones. Failure of IL-4-producing (TH2) T cell clones to activate effector function in macrophages. J Immunol 142 (1989) 760-765
11. Sypek J.P., and Wyler D.J. Antileishmanial defense in macrophages triggered by tumor necrosis factor expressed on CD4+ T lymphocyte plasma membrane. J Exp Med 174 (1991) 755-759
12. Suttles J., Miller R.W., Tao X., and Stout R.D. T cells which do not express membrane tumor necrosis factor-alpha activate macrophage effector function by cell contact-dependent signaling of macrophage tumor necrosis factor-alpha production. Eur J Immunol 24 (1994) 1736-1742
13. Alderson M.R., Armitage R.J., Tough T.W., Strockbine L., Fanslow W.C., and Spriggs M.K. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med 178 (1993) 669-674
14. Wagner Jr. D.H., Stout R.D., and Suttles J. Role of the CD40-CD40 ligand interaction in CD4+ T cell contact-dependent activation of monocyte interleukin-1 synthesis. Eur J Immunol 24 (1994) 3148-3154
15. Tian L., Noelle R.J., and Lawrence D.A. Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA-1. Eur J Immunol 25 (1995) 306-309
16. Stout R.D., Suttles J., Xu J., Grewal I.S., and Flavell R.A. Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. J Immunol 156 (1996) 8-11
17. Henn V., Slupsky J.R., Grafe M., Anagnostopoulos I., Forster R., Muller-Berghaus G., et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391 (1998) 591-594
18. Gauchat J.F., Henchoz S., Mazzei G., Aubry J.P., Brunner T., Blasey H., et al. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 365 (1993) 340-343
19. Henn V., Steinbach S., Buchner K., Presek P., and Kroczek R.A. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 98 (2001) 1047-1054
20. Ferrari-Lacraz S., Nicod L.P., Chicheportiche R., Welgus H.G., and Dayer J.M. Human lung tissue macrophages, but not alveolar macrophages, express matrix metalloproteinases after direct contact with activated T lymphocytes. Am J Respir Cell Mol Biol 24 (2001) 442-451
21. Kiener P.A., Moran-Davis P., Rankin B.M., Wahl A.F., Aruffo A., and Hollenbaugh D. Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J Immunol 155 (1995) 4917-4925
22. Mukundan L., Bishop G.A., Head K.Z., Zhang L., Wahl L.M., and Suttles J. TNF receptor-associated factor 6 is an essential mediator of CD40-activated proinflammatory pathways in monocytes and macrophages. J Immunol 174 (2005) 1081-1090
23. Kennedy M.K., Picha K.S., Fanslow W.C., Grabstein K.H., Alderson M.R., Clifford K.N., et al. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages. Eur J Immunol 26 (1996) 370-378
24. Shu U., Kiniwa M., Wu C.Y., Maliszewski C., Vezzio N., Hakimi J., et al. Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur J Immunol 25 (1995) 1125-1128
25. Kornbluth R.S., Kee K., and Richman D.D. CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive beta-chemokines. Proc Natl Acad Sci USA 95 (1998) 5205-5210
26. Wu L., Fan J., Matsumoto S., and Watanabe T. Induction and regulation of matrix metalloproteinase-12 by cytokines and CD40 signaling in monocyte/macrophages. Biochem Biophys Res Commun 269 (2000) 808-815
27. Malik N., Greenfield B.W., Wahl A.F., and Kiener P.A. Activation of human monocytes through CD40 induces matrix metalloproteinases. J Immunol 156 (1996) 3952-3960
28. Mach F., Schonbeck U., Bonnefoy J.Y., Pober J.S., and Libby P. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation 96 (1997) 396-399
29. Suttles J., Evans M., Miller R.W., Poe J.C., Stout R.D., and Wahl L.M. T cell rescue of monocytes from apoptosis: role of the CD40-CD40L interaction and requirement for CD40-mediated induction of protein tyrosine kinase activity. J Leukoc Biol 60 (1996) 651-657
30. Stout R.D., and Suttles J. T cell-macrophage cognate interaction in the activation of macrophage effector function by Th2 cells. J Immunol 150 (1993) 5330-5337
31. Suttles J., Milhorn D.M., Miller R.W., Poe J.C., Wahl L.M., and Stout R.D. CD40 signaling of monocyte inflammatory cytokine synthesis through an ERK1/2-dependent pathway. A target of interleukin (il)-4 and il-10 anti-inflammatory action. J Biol Chem 274 (1999) 5835-5842
32. Buhtoiarov I.N., Lum H., Berke G., Paulnock D.M., Sondel P.M., and Rakhmilevich A.L. CD40 ligation activates murine macrophages via an IFN-gamma-dependent mechanism resulting in tumor cell destruction in vitro. J Immunol 174 (2005) 6013-6022
33. Lum H.D., Buhtoiarov I.N., Schmidt B.E., Berke G., Paulnock D.M., Sondel P.M., et al. In vivo CD40 ligation can induce T-cell-independent antitumor effects that involve macrophages. J Leukoc Biol 79 (2006) 1181-1192
34. Kilinc M.O., Mukundan L., Yolcu E.S., Singh N.P., Suttles J., and Shirwan H. Generation of a multimeric form of CD40L with potent immunostimulatory activity using streptavidin as a chaperon. Exp Mol Pathol 80 (2006) 252-261
35. Pearson L.L., Castle B.E., and Kehry M.R. CD40-mediated signaling in monocytic cells: up-regulation of tumor necrosis factor receptor-associated factor mRNAs and activation of mitogen-activated protein kinase signaling pathways. Int Immunol 13 (2001) 273-283
36. Inoue Y., Otsuka T., Niiro H., Nagano S., Arinobu Y., Ogami E., et al. Novel regulatory mechanisms of CD40-induced prostanoid synthesis by IL-4 and IL-10 in human monocytes. J Immunol 172 (2004) 2147-2154
37. Mathur R.K., Awasthi A., Wadhone P., Ramanamurthy B., and Saha B. Reciprocal CD40 signals through p38MAPK and ERK-1/2 induce counteracting immune responses. Nat Med 10 (2004) 540-544
38. Foey A.D., Feldmann M., and Brennan F.M. CD40 ligation induces macrophage IL-10 and TNF-alpha production: differential use of the PI3K and p42/44 MAPK-pathways. Cytokine 16 (2001) 131-142
39. Martin M., Rehani K., Jope R.S., and Michalek S.M. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol 6 (2005) 777-784
40. Eliopoulos A.G., Wang C.C., Dumitru C.D., and Tsichlis P.N. Tpl2 transduces CD40 and TNF signals that activate ERK and regulates IgE induction by CD40. EMBO J 22 (2003) 3855-3864
41. Inoue J., Ishida T., Tsukamoto N., Kobayashi N., Naito A., Azuma S., et al. Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling. Exp Cell Res 254 (2000) 14-24
42. Bishop G.A. The multifaceted roles of TRAFs in the regulation of B-cell function. Nat Rev Immunol 4 (2004) 775-786
43. Bishop G.A., Moore C.R., Xie P., Stunz L.L., and Kraus Z.J. TRAF proteins in CD40 signaling. Adv Exp Med Biol 597 (2007) 131-151
44. Mackey M.F., Wang Z., Eichelberg K., and Germain R.N. Distinct contributions of different CD40 TRAF binding sites to CD154-induced dendritic cell maturation and IL-12 secretion. Eur J Immunol 33 (2003) 779-789
45. Andrade R.M., Wessendarp M., Gubbels M.J., Striepen B., and Subauste C.S. CD40 induces macrophage anti-Toxoplasma gondii activity by triggering autophagy-dependent fusion of pathogen-containing vacuoles and lysosomes. J Clin Invest 116 (2006) 2366-2377
46. Subauste C.S., Andrade R.M., and Wessendarp M. CD40-TRAF6 and autophagy-dependent anti-microbial activity in macrophages. Autophagy 3 (2007) 245-248
47. Pullen S.S., Labadia M.E., Ingraham R.H., McWhirter S.M., Everdeen D.S., Alber T., et al. High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization. Biochemistry 38 (1999) 10168-10177
48. Sinistro A., Ciaprini C., Natoli S., Sussarello E., Carducci F.C., Almerighi C., et al. Lipopolysaccharide desensitizes monocytes-macrophages to CD40 ligand stimulation. Immunology 122 (2007) 362-370
49. Sinistro A., Almerighi C., Ciaprini C., Natoli S., Sussarello E., Di F.S., et al. Downregulation of CD40 ligand response in monocytes from sepsis patients. Clin Vaccine Immunol 15 (2008) 1851-1858
50. Poe J.C., Wagner Jr. D.H., Miller R.W., Stout R.D., and Suttles J. IL-4 and IL-10 modulation of CD40-mediated signaling of monocyte IL-1beta synthesis and rescue from apoptosis. J Immunol 159 (1997) 846-852
51. Bullens D.M., Kasran A., Thielemans K., Bakkus M., and Ceuppens J.L. CD40L-induced IL-12 production is further enhanced by the Th2 cytokines IL-4 and IL-13. Scand J Immunol 53 (2001) 455-463
52. Berlato C., Cassatella M.A., Kinjyo I., Gatto L., Yoshimura A., and Bazzoni F. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation. J Immunol 168 (2002) 6404-6411
53. Dickensheets H., Vazquez N., Sheikh F., Gingras S., Murray P.J., Ryan J.J., et al. Suppressor of cytokine signaling-1 is an IL-4-inducible gene in macrophages and feedback inhibits IL-4 signaling. Genes Immun 8 (2007) 21-27
54. Jiang H., Harris M.B., and Rothman P. IL-4/IL-13 signaling beyond JAK/STAT. J Allergy Clin Immunol 105 (2000) 1063-1070
55. Sag D., Carling D., Stout R.D., and Suttles J. Adenosine 5′-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J Immunol 181 (2008) 8633-8641
56. Straus D.S., and Glass C.K. Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms. Trends Immunol 28 (2007) 551-558
57. Makowski L., Brittingham K.C., Reynolds J.M., Suttles J., and Hotamisligil G.S. The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities. J Biol Chem 280 (2005) 12888-12895
58. Faveeuw C., Fougeray S., Angeli V., Fontaine J., Chinetti G., Gosset P., et al. Peroxisome proliferator-activated receptor gamma activators inhibit interleukin-12 production in murine dendritic cells. FEBS Lett 486 (2000) 261-266
59. Futagami S., Tatsuguchi A., Hiratsuka T., Shindo T., Horie A., Hamamoto T., et al. Monocyte chemoattractant protein 1 and CD40 ligation have a synergistic effect on vascular endothelial growth factor production through cyclooxygenase 2 upregulation in gastric cancer. J Gastroenterol 43 (2008) 216-224
60. Benveniste E.N., Nguyen V.T., and Wesemann D.R. Molecular regulation of CD40 gene expression in macrophages and microglia. Brain Behav Immun 18 (2004) 7-12
61. Stout R.D., and Suttles J. The many roles of CD40 in cell-mediated inflammatory responses. Immunol Today 17 (1996) 487-492
62. Qin H., Wilson C.A., Lee S.J., Zhao X., and Benveniste E.N. LPS induces CD40 gene expression through the activation of NF-kappaB and STAT-1alpha in macrophages and microglia. Blood 106 (2005) 3114-3122
63. Wu W., Alexis N.E., Bromberg P.A., Jaspers I., and Peden D.B. Mechanisms of LPS-induced CD40 expression in human peripheral blood monocytic cells. Biochem Biophys Res Commun 379 (2009) 573-577
64. Wu W., Alexis N.E., Chen X., Bromberg P.A., and Peden D.B. Involvement of mitogen-activated protein kinases and NFkappaB in LPS-induced CD40 expression on human monocytic cells. Toxicol Appl Pharmacol 228 (2008) 135-143
65. Nguyen V.T., Walker W.S., and Benveniste E.N. Post-transcriptional inhibition of CD40 gene expression in microglia by transforming growth factor-beta. Eur J Immunol 28 (1998) 2537-2548
66. Nguyen V.T., and Benveniste E.N. IL-4-activated STAT-6 inhibits IFN-gamma-induced CD40 gene expression in macrophages/microglia. J Immunol 165 (2000) 6235-6243
67. Qin H., Wilson C.A., Roberts K.L., Baker B.J., Zhao X., and Benveniste E.N. IL-10 inhibits lipopolysaccharide-induced CD40 gene expression through induction of suppressor of cytokine signaling-3. J Immunol 177 (2006) 7761-7771
68. Garlichs C.D., John S., Schmeisser A., Eskafi S., Stumpf C., Karl M., et al. Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia. Circulation 104 (2001) 2395-2400
69. Youssef S., Stuve O., Patarroyo J.C., Ruiz P.J., Radosevich J.L., Hur E.M., et al. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 420 (2002) 78-84
70. Lee S.J., Qin H., and Benveniste E.N. Simvastatin inhibits IFN-gamma-induced CD40 gene expression by suppressing STAT-1alpha. J Leukoc Biol 82 (2007) 436-447
71. Gerritse K., Laman J.D., Noelle R.J., Aruffo A., Ledbetter J.A., Boersma W.J., et al. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci USA 93 (1996) 2499-2504
72. Durie F.H., Fava R.A., Foy T.M., Aruffo A., Ledbetter J.A., and Noelle R.J. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 261 (1993) 1328-1330
73. Carayanniotis G., Masters S.R., and Noelle R.J. Suppression of murine thyroiditis via blockade of the CD40-CD40L interaction. Immunology 90 (1997) 421-426
74. Bagenstose L.M., Agarwal R.K., Silver P.B., Harlan D.M., Hoffmann S.C., Kampen R.L., et al. Disruption of CD40/CD40-ligand interactions in a retinal autoimmunity model results in protection without tolerance. J Immunol 175 (2005) 124-130
75. Namba K., Ogasawara K., Kitaichi N., Morohashi T., Sasamoto Y., Kotake S., et al. Amelioration of experimental autoimmune uveoretinitis by pretreatment with a pathogenic peptide in liposome and anti-CD40 ligand monoclonal antibody. J Immunol 165 (2000) 2962-2969
76. Danese S., Sans M., and Fiocchi C. The CD40/CD40L costimulatory pathway in inflammatory bowel disease. Gut 53 (2004) 1035-1043
77. Balasa B., Krahl T., Patstone G., Lee J., Tisch R., McDevitt H.O., et al. CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice. J Immunol 159 (1997) 4620-4627
78. Howard L.M., Miga A.J., Vanderlugt C.L., Dal Canto M.C., Laman J.D., Noelle R.J., et al. Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis. J Clin Invest 103 (1999) 281-290
79. Howard L.M., and Miller S.D. Immunotherapy targeting the CD40/CD154 costimulatory pathway for treatment of autoimmune disease. Autoimmunity 37 (2004) 411-418
80. Becher B., Durell B.G., Miga A.V., Hickey W.F., and Noelle R.J. The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system. J Exp Med 193 (2001) 967-974
81. Ponomarev E.D., Shriver L.P., and Dittel B.N. CD40 expression by microglial cells is required for their completion of a two-step activation process during central nervous system autoimmune inflammation. J Immunol 176 (2006) 1402-1410
82. Drexler S.K., Kong P.L., Wales J., and Foxwell B.M. Cell signalling in macrophages, the principal innate immune effector cells of rheumatoid arthritis. Arthritis Res Ther 10 (2008) 216
83. Andreakos E., Rauchhaus U., Stavropoulos A., Endert G., Wendisch V., Benahmed A.S., et al. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis. Arthritis Rheum 60 (2009) 994-1005
84. Tesmer L.A., Lundy S.K., Sarkar S., and Fox D.A. Th17 cells in human disease. Immunol Rev 223 (2008) 87-113
85. Suryani S., and Sutton I. An interferon-gamma-producing Th1 subset is the major source of IL-17 in experimental autoimmune encephalitis. J Neuroimmunol 183 (2007) 96-103
86. Evans H.G., Gullick N.J., Kelly S., Pitzalis C., Lord G.M., Kirkham B.W., et al. In vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses. Proc Natl Acad Sci USA (2009)
87. Hansson G.K., and Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6 (2006) 508-519
88. Szabolcs M.J., Cannon P.J., Thienel U., Chen R., Michler R.E., Chess L., et al. Analysis of CD154 and CD40 expression in native coronary atherosclerosis and transplant associated coronary artery disease. Virchows Arch 437 (2000) 149-159
89. Mukundan L., Milhorn D.M., Matta B., and Suttles J. CD40-mediated activation of vascular smooth muscle cell chemokine production through a Src-initiated, MAPK-dependent pathway. Cell Signal 16 (2004) 375-384
90. Mach F., Schonbeck U., Sukhova G.K., Bourcier T., Bonnefoy J.Y., Pober J.S., et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci USA 94 (1997) 1931-1936
91. Buchner K., Henn V., Grafe M., de Boer O.J., Becker A.E., and Kroczek R.A. CD40 ligand is selectively expressed on CD4+ T cells and platelets: implications for CD40-CD40L signalling in atherosclerosis. J Pathol 201 (2003) 288-295
92. Mach F., Schonbeck U., Sukhova G.K., Atkinson E., and Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 394 (1998) 200-203
93. Lutgens E., Gorelik L., Daemen M.J., de Muinck E.D., Grewal I.S., Koteliansky V.E., et al. Requirement for CD154 in the progression of atherosclerosis. Nat Med 5 (1999) 1313-1316
94. Bavendiek U., Zirlik A., LaClair S., MacFarlane L., Libby P., and Schonbeck U. Atherogenesis in mice does not require CD40 ligand from bone marrow-derived cells. Arterioscler Thromb Vasc Biol 25 (2005) 1244-1249
95. Smook M.L., Heeringa P., Damoiseaux J.G., Daemen M.J., de Winther M.P., Gijbels M.J., et al. Leukocyte CD40L deficiency affects the CD25(+) CD4 T cell population but does not affect atherosclerosis. Atherosclerosis 183 (2005) 275-282
96. Zirlik A., Maier C., Gerdes N., MacFarlane L., Soosairajah J., Bavendiek U., et al. CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1. Circulation 115 (2007) 1571-1580
97. Leveille C., Bouillon M., Guo W., Bolduc J., Sharif-Askari E., El-Fakhry Y., et al. CD40 ligand binds to alpha5beta1 integrin and triggers cell signaling. J Biol Chem 282 (2007) 5143-5151
98. Mackey M.F., Barth Jr. R.J., and Noelle R.J. The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells. J Leukoc Biol 63 (1998) 418-428
99. Iezzi G., Sonderegger I., Ampenberger F., Schmitz N., Marsland B.J., and Kopf M. CD40-CD40L cross-talk integrates strong antigenic signals and microbial stimuli to induce development of IL-17-producing CD4+ T cells. Proc Natl Acad Sci USA 106 (2009) 876-881
100. Perona-Wright G., Jenkins S.J., O'Connor R.A., Zienkiewicz D., McSorley H.J., Maizels R.M., et al. A pivotal role for CD40-mediated IL-6 production by dendritic cells during IL-17 induction in vivo. J Immunol 182 (2009) 2808-2815
101. Soong L., Xu J.C., Grewal I.S., Kima P., Sun J., Longley B.J., et al. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4 (1996) 263-273
102. Chaussabel D., Jacobs F., de J.J., de V.M., Carlier Y., Thielemans K., et al. CD40 ligation prevents Trypanosoma cruzi infection through interleukin-12 upregulation. Infect Immun 67 (1999) 1929-1934
103. Chamekh M., Vercruysse V., Habib M., Lorent M., Goldman M., Allaoui A., et al. Transfection of Trypanosoma cruzi with host CD40 ligand results in improved control of parasite infection. Infect Immun 73 (2005) 6552-6561
104. Habib M., Rivas M.N., Chamekh M., Wieckowski S., Sun W., Bianco A., et al. Cutting edge: small molecule CD40 ligand mimetics promote control of parasitemia and enhance T cells producing IFN-gamma during experimental Trypanosoma cruzi infection. J Immunol 178 (2007) 6700-6704
105. Subauste C.S., and Wessendarp M. CD40 restrains in vivo growth of Toxoplasma gondii independently of gamma interferon. Infect Immun 74 (2006) 1573-1579
106. Andrade R.M., Wessendarp M., Portillo J.A., Yang J.Q., Gomez F.J., Durbin J.E., et al. TNF receptor-associated factor 6-dependent CD40 signaling primes macrophages to acquire antimicrobial activity in response to TNF-alpha. J Immunol 175 (2005) 6014-6021
107. Pietrella D., Lupo P., Perito S., Mosci P., Bistoni F., and Vecchiarelli A. Disruption of CD40/CD40L interaction influences the course of Cryptococcus neoformans infection. FEMS Immunol Med Microbiol 40 (2004) 63-70
108. Netea M.G., Meer J.W., Verschueren I., and Kullberg B.J. CD40/CD40 ligand interactions in the host defense against disseminated Candida albicans infection: the role of macrophage-derived nitric oxide. Eur J Immunol 32 (2002) 1455-1463
109. Gold J.A., Parsey M., Hoshino Y., Hoshino S., Nolan A., Yee H., et al. CD40 contributes to lethality in acute sepsis: in vivo role for CD40 in innate immunity. Infect Immun 71 (2003) 3521-3528
110. Nolan A., Weiden M.D., Hoshino Y., and Gold J.A. Cd40 but not CD154 knockout mice have reduced inflammatory response in polymicrobial sepsis: a potential role for Escherichia coli heat shock protein 70 in CD40-mediated inflammation in vivo. Shock 22 (2004) 538-542
111. Wang Y., Kelly C.G., Karttunen J.T., Whittall T., Lehner P.J., Duncan L., et al. CD40 is a cellular receptor mediating mycobacterial heat shock protein 70 stimulation of CC-chemokines. Immunity 15 (2001) 971-983
112. Rub A., Dey R., Jadhav M., Kamat R., Chakkaramakkil S., Majumdar S., et al. Cholesterol depletion associated with Leishmania major infection alters macrophage CD40 signalosome composition and effector function. Nat Immunol 10 (2009) 273-280